Nisa Investment Advisors, LLC Akebia Therapeutics, Inc. Transaction History

Nisa Investment Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$0.32 - $0.67 $514 - $1,077	-1,608 Closed	0 $0
Q1 2022 Apr 29, 2022	SELL	$0.72 - $2.93 $255,312 - $1.04 Million	-354,600 Reduced 99.55%	1,608 $1,000
Q4 2021 Feb 03, 2022	SELL	$2.26 - $3.34 $13,559 - $20,040	-6,000 Reduced 1.66%	356,208 $709,000
Q2 2021 Aug 06, 2021	BUY	$2.83 - $4.2 $56,600 - $84,000	20,000 Added 5.84%	362,208 $1.37 Million
Q4 2020 Jan 25, 2021	BUY	$2.22 - $3.78 $745,809 - $1.27 Million	335,950 Added 5368.33%	342,208 $958,000

Q3 2020 Oct 20, 2020	BUY	$2.39 - $13.08 $11,113 - $60,822	4,650 Added 289.18%	6,258 $16,000
Q2 2020 Jul 27, 2020	BUY	$6.67 - $13.58 $2,534 - $5,160	380 Added 30.94%	1,608 $22,000
Q3 2019 Oct 17, 2019	BUY	$3.55 - $5.4 $3,017 - $4,590	850 Added 224.87%	1,228 $5,000
Q4 2018 Jan 17, 2019	BUY	$5.39 - $9.15 $2,037 - $3,458	378 New	378 $2,000

127

56.7M

937K

743K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $188M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.